According to the National Institutes of Health (NIH), combination
therapies that include
And PEG-INTRON® comes to you from a trusted leader in the field, with unequalled experience in hepatitis C treatment and a history of U.S. prescriptions of more than 230,000 patients.
Starting strong on PEG-INTRON® means that, after 4 weeks of treatment, it's possible that much less virus is present in your body. Such a rapid viral response (RVR) helps predict success later on. The faster the virus level in your body decreases on its way to an undetectable level, the more likely you are to sustain a viral response.1 Starting strong helps you finish strong.
People who respond to their treatment with PEG-INTRON® combination therapy after 48 weeks show a low level of relapse. In a clinical trial, 82% of those who acheived an end-of-treatment response at week 48 had undetectable levels of virus 6 months later2.
One reason that the PEG-INTRON® molecule may work so well to eliminate hepatitis C from your body is because of it's relatively small size. This gives PEG-INTRON® extensive biodistribution, which is a measure of how well the medication penetrates throughout your body to where it can do the most good. Watch this video to learn more about the biodistribution of PEG-INTRON®.
1 Silva M. A randomized trial to compare the pharmacokinetic, pharmacodynamic, and anti viral effects of peginterferon alpha-2b and peginterferon alpha-2a in patients with chronic hepatitis C (COMPARE). Journal of Hepatology August 2006.
2 Manns MP, McHutchison JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet. 2001;358:958-965.
